Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369467
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-04-11
Brief Title:
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E IgE-Mediated Food Allergy
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-11
First Submit QC Date:
April 11 2024
Study First Post Date:
2024-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-19
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL